|
On Friday, the CDC notified state and local health department vaccination grantees that the FDA is considering discontinuing the Emergency Use Authorization (EUA) for Pfizer’s COVID-19 vaccine for children aged 6 months–4 years. In brief:
- Pfizer’s pediatric COVID-19 vaccine for 6m–4y may not be renewed by the FDA for the 2025–2026 season.
- For children aged 5y–11y, Pfizer anticipates full licensure for this vaccine presentation, pending regulatory action.
- Moderna’s Spikevax® recently received full licensure for children with certain health conditions. Pending FDA approval of its 2025–2026 formulation, Moderna plans to increase supply for children 11y and younger to help address potential gaps.
- Novavax’s pediatric COVID-19 vaccine remains available for children aged 12+ with certain health conditions.
With COVID-19 cases rising in many parts of the U.S., we understand the need for clear guidance on vaccine availability this fall and the concern about potential supply gaps, particularly if providers have not ordered from manufacturers for several months.
CDC is in active discussions with Moderna, which is finalizing internal planning to determine specific supply volumes and timelines. They are confident they will be able to help mitigate any potential shortage.
We will share further updates on pediatric COVID-19 vaccine availability for the 2025–2026 season as soon as new information is confirmed.
We have been notified that there are some vaccine orders experiencing shipping delays during transit. The affected orders were sent from the distributor on Thursday, August 7th and Monday, August 11th and have been rerouted back to the distributor where viability will be determined. If deemed viable, they will be processed for reshipment. If the vaccines are no longer viable, a replacement order will be processed. This can take up to 5 business days, plus shipping time.
Please remember not to reject the order from the Inbound Order List - you will need it to receive the shipment when it arrives. You do not need to place a new order - your original order will either be reshipped or a replacement will be sent.
We apologize for the inconvenience. If you have additional questions regarding your order, please don't hesitate to contact us at WAChildhoodVaccines@doh.wa.gov.
As we prepare for the fall respiratory season, the Department of Health, WVA, and WCAAP are asking Childhood Vaccine Program providers and partners to help reduce waste of high-cost vaccines like COVID-19 and Nirsevimab. Over 11,000 vials of COVID-19 vaccine remain in the field and are at risk of being wasted, and thousands of Nirsevimab doses are set to expire this fall. While there is no shortage of COVID-19 or RSV vaccine, we need your help to be good stewards of these valuable resources, so we can continue to maintain a system that supports equitable access and operational efficiency for providers across our state.
Providers are encouraged to check inventory, post excess doses on the IIS Vaccine Advertisement page, and order smaller amounts more frequently.
For help with transfers, please refer to the Vaccine Transfer Checklist and FAQs; information on vaccine ordering, returns and choice can be found here. You can also reach out to us at WAChildhoodVaccines@doh.wa.gov.
Read the full message and guidance here
Join us for the next CVP Training Series on Thursday, August 21st. Learn about new inventory and ordering controls that will be put in place for the upcoming respiratory season to help reduce vaccine loss. These changes reflect our shared responsibility to reduce waste, maximize access, and protect the sustainability of our universal vaccine purchase program.
This training is required for all enrolled providers. Whoever places vaccine orders will need to either attend this training or watch the recording when it is available.
Date: August 21, 2025
Time: 12 noon
Primary Audience: Providers, Vaccine Coordinators, and Office Managers for the Childhood Vaccine Program
Register Here
The WA Immunization Information System (IIS) will be unavailable Saturday, August 23rd, to implement a Single Sign-On (SSO) login process. HL7 messages will not be accepted, and users will be unable to login during this time. All IIS users will need to follow the linking process outlined in the Single Sign-On (SSO) for WA IIS Users guide to log into the IIS after 8/23/25.
In preparation for this change, we are advising that all WA IIS users ensure their accounts have an email address BEFORE 8/23/2025.
 Reach out to WAIISHelpDesk@doh.wa.govif you have any questions or need assistance with the WA IIS.
The Washington State Department of Health has shared updated information on COVID-19 vaccine insurance coverage. This includes key details on coverage and billing through Apple Health (Medicaid) and private insurers. Health care providers are encouraged to review the summary and share it within their networks.
The Department continues to recommend that everyone 6 months and older, including pregnant people, receive the current COVID-19 vaccine to help protect against severe illness. This guidance is informed by the Washington State Vaccine Advisory Committee (VAC), which advises on strategies to prevent vaccine-preventable diseases.
DOH remains committed to ensuring equitable vaccine access and will continue providing timely updates. Additional resources, are available on the COVID-19 Vaccine Information for Health Care Providers webpage.
This is general COVID billing guidance for all healthcare providers. For detailed Childhood Vaccine Program billing requirements, please review the CVP billing guide.
Continuing education credits are once again available for pharmacists and pharmacy technicians who complete the . Thank you for your patience!
Please remember that each individual using the Washington State Immunization Information System (IIS) is required to have their own login. Login credentials should not be shared.
Don't have one? Reach out to the IIS Help Desk at 1-800-325-5599 or by email at WAIISHelpDesk@doh.wa.gov to setup a user account.
|
